Skip to main content

Table 1 Clinicopathologic features of the breast cancer patients (n =1901)

From: Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast

Characteristics

Whole cohort

Alive

Died of breast cancer

P value

N = 1901 (%)

N = 1828 (%)

N = 73 (%)

Age

   

0.290

≤70

1440 (75.7)

1389 (76.0)

51 (69.9)

 

>70

461 (24.3)

439 (24.0)

22 (30.1)

 

Race

   

0.206

White people

1484 (78.1)

1433 (78.4)

51 (69.9)

 

Black people

224 (11.8)

213 (11.7)

11 (15.1)

 

Other people

193 (10.2)

182 (10.0)

11 (15.1)

 

Marital status

   

0.003

Unmarried

792 (41.7)

749 (41.0)

43 (58.9)

 

Married

1109 (58.3)

1079 (59.0)

30 (41.1)

 

Tumor size

   

<0.001

≤20 mm

1137 (59.8)

1115 (61.0)

22 (30.1)

 

21-50 mm

589 (31.0)

556 (30.4)

33 (45.2)

 

>50 mm

175 (9.2)

157 (8.6)

18 (24.7)

 

N status

   

<0.001

N0

1053 (55.4)

1030 (56.3)

23 (31.5)

 

N1

547 (28.8)

529 (28.9)

18 (24.7)

 

N2

187 (9.8)

174 (9.5)

13 (17.8)

 

N3

114 (6.0)

95 (5.2)

19 (26.0)

 

eLN, mean (SD)

6.6 (7.2)

6.4 (7.1)

10.6 (8.1)

<0.001

pLN, mean (SD)

1.9 (4.0)

1.8 (3.7)

5.6 (7.2)

<0.001

TNM staging (AJCC-8th)

   

<0.001

I

819 (43.1)

804 (44.0)

15 (20.5)

 

II

733 (38.6)

707 (38.7)

26 (35.6)

 

III

349 (18.4)

317 (17.3)

32 (43.8)

 

Histological grade

   

<0.001

I-II

1239 (65.2)

1217 (66.6)

22 (30.1)

 

III-IV

662 (34.8)

611 (33.4)

51 (69.9)

 

Estrogen receptor status

   

<0.001

Negative

146 (7.7)

125 (6.8)

21 (28.8)

 

Positive

1755 (92.3)

1703 (93.2)

52 (71.2)

 

Progesterone receptor status

   

<0.001

Negative

317 (16.7)

283 (15.5)

34 (46.6)

 

Positive

1584 (83.3)

1545 (84.5)

39 (53.4)

 

Her-2 status

   

0.290

Negative

1508 (79.3)

1446 (79.1)

62 (84.9)

 

Positive

393 (20.7)

382 (20.9)

11 (15.1)

 

Molecular subtypes

   

<0.001

Luminal A

1444 (76.0)

1397 (76.4)

47 (64.4)

 

Luminal B

319 (16.8)

312 (17.1)

7 (9.6)

 

Her-2 overexpression

74 (3.9)

70 (3.8)

4 (5.5)

 

Triple negative

64 (3.4)

49 (2.7)

15 (20.5)

 

Surgery

   

<0.001

Breast conserving surgery

1078 (56.7)

1052 (57.5)

26 (35.6)

 

Mastectomy

823 (43.3)

776 (42.5)

47 (64.4)

 

Radiotherapy

   

0.389

No\Unknown

780 (41.0)

746 (40.8)

34 (46.6)

 

Yes

1121 (59.0)

1082 (59.2)

39 (53.4)

 

Chemotherapy

   

0.028

No\Unknown

981 (51.6)

953 (52.1)

28 (38.4)

 

Yes

920 (48.4)

875 (47.9)

45 (61.6)

 
  1. Abbreviations: eLN excised lymph node, pLN positive lymph node, SD Standard deviation, TNM Tumor-node-metastasis, AJCC American Joint Committee on Cancer, Her-2 Human epidermal growth factor receptor-2